Stock Events

Stock Events

Grace Therapeutics (GRCE) Q3 2024 Earnings

9AugConfirmed

Q3 2024

-0.27

-0.26

-0.25

-0.24

Details

Expected EPS

-0.265

Actual EPS

-0.24

Surprise EPS

0.03

Surprise Percent

+9.43%

Description

Grace Therapeutics (GRCE) has reported earnings of -0.24 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.